Monthly Archives: February 2024

Eli Lilly and Company Ltd has recently launched Mounjaro® (tirzepatide), a new diabetes drug which is also indicated for the treatment of weight loss. Mounjaro® comes in a KwikPen® or auto-injector pre-filled injection pen containing 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg of tirzepatide. Currently, only the 2.5mg and 5mg strengths of the KwikPen® are [...]

The post Mounjaro® (Tirzepatide) KwikPen® – availability and reimbursement appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Epilim® (sodium valproate) syrup 200mg/5ml MSN/2024/023 Tier 2 – medium impact Date of issue: 21st February 2024 Epilim® 200mg/5ml syrup is out of stock from mid-March until w/c 22nd April 2024. Epilim® (sodium valproate) 200mg/5ml liquid (sugar-free) remains available and can [...]

The post Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml appeared first on Community Pharmacy England.

Following the launch of NHS England’s (NHSE) ‘Think Pharmacy first’ campaign on Monday (19th February),  campaign materials are now available for pharmacy teams to use. The campaign materials are available on the Department of Health and Social Care’s Campaign Resource Centre website and include: A campaign toolkit; Social assets; and Posters. View the ‘Think Pharmacy [...]

The post Pharmacy First: NHSE campaign materials now available appeared first on Community Pharmacy England.

Ahead of the 31st March 2024 deadline, we would like to remind pharmacy owners of the need to update NHS Profile Manager to ensure that their pharmacy’s NHS website and Directory of Service (DoS) profile information is up to date. The NHS Terms of Service require pharmacy owners to check that their opening hours, contact [...]

The post Verifying your NHS Profile Manager profile appeared first on Community Pharmacy England.